Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 473 All time
- Disclosed funding
- $19.6B 400 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| OB Octarine BioCompany profile Octarine Bio develops bio-based pigments through precision fermentation for textiles and other industrial applications. Octarine Bio develops bio-based pigments through precision fermentation for textiles and other industrial applications. | €5M | Series A extensionSeries A | Biotech | Denmark | Investors | |
| M Develops and commercializes rare disease therapies using AI | $82M | Series A | Biotech | United States | Investors | |
| I InfinitopesCompany profile Develops precision therapeutic vaccines against multiple solid tumour indications Develops precision therapeutic vaccines against multiple solid tumour indications | $15.4M | Seed | Biotech | United Kingdom | Investors | |
| P Provides AI-powered commercial intelligence for Life Sciences organizations | $6M | Seed | Biotech | United States | Investors | |
| TB Think BioscienceCompany profile Develops small molecule drugs for historically challenging drug targets Develops small molecule drugs for historically challenging drug targets | $55M | Series A | Biotech | United States | Investors | |
| E ExcivaCompany profile Develops novel therapies for behavioral symptoms associated with Alzheimer's Disease Develops novel therapies for behavioral symptoms associated with Alzheimer's Disease | €51M | Series B | Biotech | Germany | Investors | |
| B BIOMAKERS analyzes clinical and genomic information. | $8M | Undisclosed | Biotech | United States | Investors | |
| C Cancilico develops AI diagnostic software for hematology. | €2.5M | Seed | Biotech, Healthtech | Germany | Investors | |
| AI Anzen IndustriesCompany profile Anzen Industries, now operating as Tera, develops modular cell-free enzyme reactors for manufacturing high-value chemicals. Anzen Industries, now operating as Tera, develops modular cell-free enzyme reactors for manufacturing high-value chemicals. | $2.2M | Pre-seed | Biotech | United States | Investors | |
| C Develops cell therapy platform for liver disease | $60M | Series A | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1RA Capital Management
Estuary Biotherapeutics, Circle Pharma, Inc., Solstice Oncology
22rounds3led - 2Janus Henderson Investors
Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics
15rounds1led - 3Eli Lilly and Company
BigHat Biosciences, Circle Pharma, Inc., Moonwalk Biosciences
15rounds0led - 4ARCH Venture Partners
Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences
14rounds0led - 5OrbiMed
Star Therapeutics, Leal Therapeutics, Accro Bioscience
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →